CRM Inked Collaboration with NCC Japan for Cancer Research
CRM signed an MoU with National Cancer Center Hospital Japan earlier today, witnessed by Health DDG (Research & Technical Support), Dr Hishamshah. The partnership with Japan’s top oncology hospital paves the way to progressive oncology drug development in the country and region.
As one of the partners in Asia for the ATLAS (Asian clinical TriaLs network for cAncerS) project established by the National Cancer Center Japan (NCCJ), Malaysia will benefit from early phase oncology drug development, cancer genomic medicine advancement and drug access and development.
The MoU with NCCH spells out collaboration in the areas of cancer research that includes infrastructure development, training opportunities in clinical research, participation in rare cancer clinical trial, networking opportunities as well as visits/attachments by research experts from both countries.